List of Excipients in API nicotine polacrilex lozenge 2 mg
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing nicotine polacrilex lozenge 2 mg
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 | ACACIA |
| Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 | GLYCERIN |
| Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 | MAGNESIUM STEARATE |
| Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 | MANNITOL |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for nicotine polacrilex lozenge 2 mg
Excipient focus: ACACIA
nicotine polacrilex lozenge 2 mg drug variants containing ACACIA
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
| Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
| >Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing ACACIA
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
nicotine polacrilex lozenge 2 mg drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
| Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
| >Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
nicotine polacrilex lozenge 2 mg drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
| Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
| >Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
nicotine polacrilex lozenge 2 mg drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
| Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
| >Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MENTHA ARVENSIS LEAF OIL
nicotine polacrilex lozenge 2 mg drug variants containing MENTHA ARVENSIS LEAF OIL
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
| Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
| >Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing MENTHA ARVENSIS LEAF OIL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MENTHOL
nicotine polacrilex lozenge 2 mg drug variants containing MENTHOL
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
| Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
| >Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing MENTHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PEPPERMINT OIL
nicotine polacrilex lozenge 2 mg drug variants containing PEPPERMINT OIL
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
| Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
| >Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing PEPPERMINT OIL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLACRILIN
nicotine polacrilex lozenge 2 mg drug variants containing POLACRILIN
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
| Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
| >Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing POLACRILIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM BICARBONATE
nicotine polacrilex lozenge 2 mg drug variants containing POTASSIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
| Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
| >Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing POTASSIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM ALGINATE
nicotine polacrilex lozenge 2 mg drug variants containing SODIUM ALGINATE
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
| Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
| >Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing SODIUM ALGINATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CARBONATE
nicotine polacrilex lozenge 2 mg drug variants containing SODIUM CARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
| Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
| >Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing SODIUM CARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
nicotine polacrilex lozenge 2 mg drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
| Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
| >Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
nicotine polacrilex lozenge 2 mg drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
| Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
| >Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: XANTHAN GUM
nicotine polacrilex lozenge 2 mg drug variants containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
| Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
| >Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
